IDENTIFICATION OF PROGNOSTIC GROUPS IN FOLLICULAR LYMPHOMA

被引：36

作者：

CAMERON, DA ^{[1
]}

LEONARD, RCF ^{[1
]}

MAO, JH ^{[1
]}

PRESCOTT, RJ ^{[1
]}

ALLAN, NC ^{[1
]}

BARRETT, A ^{[1
]}

DAS, SN ^{[1
]}

DAWSON, AA ^{[1
]}

HEPPLESTON, A ^{[1
]}

LENNARD, AL ^{[1
]}

LEONARD, RCF ^{[1
]}

LESSELLS, AM ^{[1
]}

LUCIE, NP ^{[1
]}

LUCRAFT, HH ^{[1
]}

MACKIE, MJ ^{[1
]}

MACLAREN, KS ^{[1
]}

MATHESON, LM ^{[1
]}

PARKER, AC ^{[1
]}

PRESCOTT, RJ ^{[1
]}

PROCTOR, SJ ^{[1
]}

ROBERTSON, AG ^{[1
]}

SARKAR, TK ^{[1
]}

SOUKOP, M ^{[1
]}

STEWARD, WP ^{[1
]}

TANSEY, PJ ^{[1
]}

WHITE, JM ^{[1
]}

机构：

[1] WESTERN GEN HOSP,DEPT MED ONCOL,CREWE RD,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND

来源：

LEUKEMIA & LYMPHOMA | 1993年 / 10卷 / 1-2期

关键词：

PROGNOSTIC GROUPS; FOLLICULAR LYMPHOMA;

D O I：

10.3109/10428199309147361

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Follicular lymphoma is often seen as an indolent disease with a reasonable medium-term survival. We have used the information in the Scotland and Newcastle Lymphoma Group database to devise an index which is easily calculated and differentiates patients into poor, intermediate and good prognostic groups with 5 year survivals of 24%, 61% and 86% respectively. The key factors at presentation are age, ECOG performance status, stage and the presence or absence of B symptoms or gastro-intestinal tract involvement. The use of such an index permits early identification of patients with a poor prognosis for whom more intensive treatment could be offered.

引用

页码：89 / 99

页数：11

共 10 条

[1]

Paryani S.B., Hoppe R.T., Cox R.S., Colby T.V., Rosenberg S.A., Kaplan H.S., Analysis of non-Hodgkin's lymphomas with nodular and favorable histologies, Stages I and II, Cancer, 52, pp. 2300-2307, (1983)

[2]

Rosenberg S.A., Karnofsky memorial lecture: The natural history of low grade malignant lymphoma, J. Clin. One, 3, pp. 299-310, (1985)

[3]

Portlock C.S., Rosenberg S.A., No initial therapy for stage III and IV non-Hodgkin's lymphomas of favorable histologic types, Ann. Intern. Med., 90, pp. 10-13, (1979)

[4]

O'Brien M.E.R., Easterbrook P., Powell J., Blackledge G.R.P., Jones L., MacLennan I.C.M., Leonard R.C.F., The natural history of low grade non-Hodgkin's lymphoma and the impact of a no inital treatment policy on survival, Quarterly Journal Med, 292, pp. 651-660, (1991)

[5]

Paryani S.B., Hoppe R.T., Cox R.S., Colby T.V., Kaplan H.S., The role of radiation therapy in the management of stage III follicular lymphomas, J. Clin. One, 2, pp. 841-848, (1984)

[6]

Leonard R.C.F., Hayward R.L., Prestcott R.J., Wang J.X., The identification of discrete prognostic groups in low grade non-Hodgkin's Lymphoma, Annals of Oncology, 2, pp. 655-662, (1991)

[7]

Chabner B.A., Johnson R.E., DeVita V.T., Et al., Sequential staging in non-Hodgkin's lymphoma, Cancer Treat. Rep., 61, pp. 993-998, (1977)

[8]

Gopsodarowicz M.K., Bush R.S., Brown T.C., Chua T., Prognostic factors in nodular lymphomas: a multi-variate analysis based on the Princess Margaret Hospital experience, Int. J. Radiation Oncology Biol. Phys., 10, pp. 489-497, (1984)

[9]

Gallagher C.J., Gregory W.M., Jones A.E., Stansfield A.G., Richards M.A., Dhaliwal H.S., Malpas J.S., Lister T.A., Follicular lymphoma: prognostic factors for response and survival, J. Clin. One, 4, pp. 1470-1480, (1986)

[10]

Stein R.S., Cousar J., Flexner J.M., Et al., Malignant lumphomas of follicular centre cell origin in man. III: prognostic factors, Cancer, 44, pp. 2236-2243, (1979)

← 1 →